Stock comparison
Globus Medical
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GMED
Globus Medical
Market cap
$11.44B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GMED | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 58C | 69B | MTD |
| Benjamin Graham | 65B | 65B | Tie |
| Philip Fisher | 70C | 63C | GMED |
| Peter Lynch | 63C | 66B | MTD |
| Joel Greenblatt | 45D | 68B | MTD |
| Charlie Munger | 51D | 74B | MTD |
| Terry Smith | 56D | 70B | MTD |
Side-by-side metrics
| Metric | GMED | MTD |
|---|---|---|
| Market cap | $11.44B | $22.29B |
| P/E (TTM) | 17.7x | 25.3x |
| EV/EBIT | 20.6x | 21.6x |
| ROIC (TTM) | 9.72% | 36.09% |
| Gross margin | 67.86% | 57.79% |
| Net margin | 18.92% | 21.4% |
| Revenue CAGR 5y | 32.34% | 2.01% |
| EPS CAGR 5y | 28.06% | 6.12% |
| Debt / Equity | 0.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GMED leads on
- Revenue CAGR 5y32.34%vs 2.01%+94%
- EPS CAGR 5y28.06%vs 6.12%+78%
- P/E (TTM)17.7xvs 25.3x+30%
- Gross margin67.86%vs 57.79%+15%
MTD leads on
- Debt / Equity-vs 0.0x+100%
- ROIC (TTM)36.09%vs 9.72%+73%
- Market cap$22.29Bvs $11.44B+49%
- Net margin21.4%vs 18.92%+12%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.